HomeABOS • NASDAQ
add
Acumen Pharmaceuticals Inc
Previous close
$1.01
Day range
$1.00 - $1.09
Year range
$0.86 - $3.92
Market cap
64.81M USD
Avg Volume
224.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.10M | -4.15% |
Net income | -28.80M | -93.61% |
Net profit margin | — | — |
Earnings per share | -0.48 | -92.00% |
EBITDA | -30.36M | -70.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.15M | -40.93% |
Total assets | 204.48M | -32.06% |
Total liabilities | 48.96M | 25.75% |
Total equity | 155.52M | — |
Shares outstanding | 60.57M | — |
Price to book | 0.39 | — |
Return on assets | -34.24% | — |
Return on capital | -38.27% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -28.80M | -93.61% |
Cash from operations | -34.12M | -91.06% |
Cash from investing | 28.69M | 411.74% |
Cash from financing | -36.00K | -100.51% |
Net change in cash | -5.47M | 72.60% |
Free cash flow | -24.53M | -85.86% |
About
Founded
Jan 1, 1996
Headquarters
Website
Employees
61
